EdgarLookup

Protara Therapeutics, Inc. — 8-K Filings

123 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Protara Therapeutics, Inc. (TARA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Protara Therapeutics, Inc. has filed 123 8-K documents with the SEC since 2006. To view all SEC filings by Protara Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 3 3/A 4 4/A 424B3 424B4 424B5 424B7 425 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A REGDEX REGDEX/A RW S-1 S-1/A S-1MEF S-3 S-3/A S-3MEF S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-025432 Mar 10, 2026
8-K CURRENT REPORT 0001213900-26-019617 Feb 24, 2026 Feb 23, 2026
8-K CURRENT REPORT 0001213900-25-121687 Dec 15, 2025
8-K CURRENT REPORT 0001213900-25-119242 Dec 8, 2025 Dec 4, 2025
8-K CURRENT REPORT 0001213900-25-117577 Dec 3, 2025
8-K CURRENT REPORT 0001213900-25-112383 Nov 19, 2025
8-K CURRENT REPORT 0001213900-25-107873 Nov 10, 2025
8-K CURRENT REPORT 0001213900-25-073937 Aug 11, 2025
8-K CURRENT REPORT 0001213900-25-053844 Jun 12, 2025 Jun 11, 2025
8-K CURRENT REPORT 0001213900-25-040809 May 8, 2025
8-K CURRENT REPORT 0001213900-25-035785 Apr 28, 2025 Apr 26, 2025
8-K CURRENT REPORT 0001213900-25-020366 Mar 5, 2025
8-K CURRENT REPORT 0001213900-25-003026 Jan 13, 2025
8-K CURRENT REPORT 0001213900-24-107906 Dec 11, 2024 Dec 9, 2024
8-K CURRENT REPORT 0001213900-24-105782 Dec 5, 2024
8-K CURRENT REPORT 0001213900-24-096243 Nov 12, 2024
8-K CURRENT REPORT 0001213900-24-065378 Aug 6, 2024
8-K CURRENT REPORT 0001213900-24-051210 Jun 10, 2024 Jun 7, 2024
8-K CURRENT REPORT 0001213900-24-038756 May 2, 2024
8-K CURRENT REPORT 0001213900-24-030623 Apr 5, 2024
8-K CURRENT REPORT 0001213900-24-023589 Mar 18, 2024
8-K CURRENT REPORT 0001213900-24-021981 Mar 13, 2024
8-K CURRENT REPORT 0001213900-23-083011 Nov 3, 2023
8-K CURRENT REPORT 0001213900-23-062780 Aug 3, 2023
8-K CURRENT REPORT 0001213900-23-047460 Jun 8, 2023 Jun 7, 2023
8-K CURRENT REPORT 0001213900-23-036112 May 4, 2023
8-K CURRENT REPORT 0001213900-23-035154 May 2, 2023
8-K CURRENT REPORT 0001213900-23-033507 Apr 28, 2023
8-K CURRENT REPORT 0001213900-23-019281 Mar 10, 2023
8-K CURRENT REPORT 0001213900-23-018371 Mar 8, 2023
8-K CURRENT REPORT 0001213900-23-005811 Jan 30, 2023
8-K CURRENT REPORT 0001213900-23-001140 Jan 5, 2023
8-K CURRENT REPORT 0001213900-22-068819 Nov 3, 2022
8-K CURRENT REPORT 0001213900-22-045601 Aug 9, 2022
8-K CURRENT REPORT 0001213900-22-039976 Jul 18, 2022 Jul 16, 2022
8-K CURRENT REPORT 0001213900-22-033756 Jun 21, 2022 Jun 20, 2022
8-K CURRENT REPORT 0001213900-22-031985 Jun 9, 2022 Jun 8, 2022
8-K CURRENT REPORT 0001213900-22-024098 May 5, 2022
8-K FORM 8-K 0001213900-22-011205 Mar 9, 2022
8-K CURRENT REPORT 0001213900-22-001222 Jan 10, 2022
8-K CURRENT REPORT 0001213900-21-056585 Nov 4, 2021
8-K CURRENT REPORT 0001213900-21-053303 Oct 18, 2021 Oct 15, 2021
8-K CURRENT REPORT 0001213900-21-052250 Oct 12, 2021
8-K CURRENT REPORT 0001213900-21-040412 Aug 5, 2021
8-K CURRENT REPORT 0001213900-21-031798 Jun 10, 2021 Jun 9, 2021
8-K CURRENT REPORT 0001213900-21-022652 Apr 23, 2021
8-K CURRENT REPORT 0001213900-21-022105 Apr 19, 2021
8-K CURRENT REPORT 0001213900-21-016115 Mar 17, 2021 Mar 12, 2021
8-K CURRENT REPORT 0001213900-21-013062 Mar 3, 2021
8-K CURRENT REPORT 0001213900-21-008283 Feb 11, 2021